271 related articles for article (PubMed ID: 32012790)
21. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
22. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
23. WRN loss induces switching of telomerase-independent mechanisms of telomere elongation.
Gocha AR; Acharya S; Groden J
PLoS One; 2014; 9(4):e93991. PubMed ID: 24709898
[TBL] [Abstract][Full Text] [Related]
24. Resolving Roadblocks to Telomere Replication.
Mason-Osann E; Gali H; Flynn RL
Methods Mol Biol; 2019; 1999():31-57. PubMed ID: 31127568
[TBL] [Abstract][Full Text] [Related]
25. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Amato R; Valenzuela M; Berardinelli F; Salvati E; Maresca C; Leone S; Antoccia A; Sgura A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183119
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).
Falcinelli M; Dell'Omo G; Grassi E; Mariella E; Leto SM; Scardellato S; Lorenzato A; Arena S; Bertotti A; Trusolino L; Bardelli A; d'Adda di Fagagna F
Cell Death Dis; 2023 Feb; 14(2):96. PubMed ID: 36759506
[TBL] [Abstract][Full Text] [Related]
27. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
28. Alternative lengthening of human telomeres is a conservative DNA replication process with features of break-induced replication.
Roumelioti FM; Sotiriou SK; Katsini V; Chiourea M; Halazonetis TD; Gagos S
EMBO Rep; 2016 Dec; 17(12):1731-1737. PubMed ID: 27760777
[TBL] [Abstract][Full Text] [Related]
29. Alternative paths to telomere elongation.
Lee JJ; Lee J; Lee H
Semin Cell Dev Biol; 2021 May; 113():88-96. PubMed ID: 33293233
[TBL] [Abstract][Full Text] [Related]
30. The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
Feng X; Luo Z; Jiang S; Li F; Han X; Hu Y; Wang D; Zhao Y; Ma W; Liu D; Huang J; Songyang Z
J Cell Sci; 2013 Sep; 126(Pt 17):3982-9. PubMed ID: 23813958
[TBL] [Abstract][Full Text] [Related]
31. Alternative lengthening of telomeres in cancer stem cells in vivo.
Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
[TBL] [Abstract][Full Text] [Related]
32. New twists to the ALTernative endings at telomeres.
Bhargava R; Lynskey ML; O'Sullivan RJ
DNA Repair (Amst); 2022 Jul; 115():103342. PubMed ID: 35588569
[TBL] [Abstract][Full Text] [Related]
33. XPF activates break-induced telomere synthesis.
Guh CY; Shen HJ; Chen LW; Chiu PC; Liao IH; Lo CC; Chen Y; Hsieh YH; Chang TC; Yen CP; Chen YY; Chen TW; Chen LY; Wu CS; Egly JM; Chu HC
Nat Commun; 2022 Oct; 13(1):5781. PubMed ID: 36184605
[TBL] [Abstract][Full Text] [Related]
34. Hyperextended telomeres promote formation of C-circle DNA in telomerase positive human cells.
Jones CY; Williams CL; Moreno SP; Morris DK; Mondello C; Karlseder J; Bertuch AA
J Biol Chem; 2023 May; 299(5):104665. PubMed ID: 37003504
[TBL] [Abstract][Full Text] [Related]
35. Caenorhabditis elegans POT-2 telomere protein represses a mode of alternative lengthening of telomeres with normal telomere lengths.
Cheng C; Shtessel L; Brady MM; Ahmed S
Proc Natl Acad Sci U S A; 2012 May; 109(20):7805-10. PubMed ID: 22547822
[TBL] [Abstract][Full Text] [Related]
36. Telomere sequence content can be used to determine ALT activity in tumours.
Lee M; Teber ET; Holmes O; Nones K; Patch AM; Dagg RA; Lau LMS; Lee JH; Napier CE; Arthur JW; Grimmond SM; Hayward NK; Johansson PA; Mann GJ; Scolyer RA; Wilmott JS; Reddel RR; Pearson JV; Waddell N; Pickett HA
Nucleic Acids Res; 2018 Jun; 46(10):4903-4918. PubMed ID: 29718321
[TBL] [Abstract][Full Text] [Related]
37. Alternative lengthening of telomeres in human cells.
Reddel RR; Bryan TM; Colgin LM; Perrem KT; Yeager TR
Radiat Res; 2001 Jan; 155(1 Pt 2):194-200. PubMed ID: 11121234
[TBL] [Abstract][Full Text] [Related]
38. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Lovejoy CA; Li W; Reisenweber S; Thongthip S; Bruno J; de Lange T; De S; Petrini JH; Sung PA; Jasin M; Rosenbluh J; Zwang Y; Weir BA; Hatton C; Ivanova E; Macconaill L; Hanna M; Hahn WC; Lue NF; Reddel RR; Jiao Y; Kinzler K; Vogelstein B; Papadopoulos N; Meeker AK;
PLoS Genet; 2012; 8(7):e1002772. PubMed ID: 22829774
[TBL] [Abstract][Full Text] [Related]
39. Highlighting vulnerabilities in the alternative lengthening of telomeres pathway.
Carson LM; Flynn RL
Curr Opin Pharmacol; 2023 Jun; 70():102380. PubMed ID: 37149932
[TBL] [Abstract][Full Text] [Related]
40. Pathway choice in the alternative telomere lengthening in neoplasia is dictated by replication fork processing mediated by EXD2's nuclease activity.
Broderick R; Cherdyntseva V; Nieminuszczy J; Dragona E; Kyriakaki M; Evmorfopoulou T; Gagos S; Niedzwiedz W
Nat Commun; 2023 Apr; 14(1):2428. PubMed ID: 37105990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
